Apical hypertrophic cardiomyopathy, are low-risk patients really at low risk? A case report

Eur Heart J Case Rep. 2020 Sep 23;4(5):1-4. doi: 10.1093/ehjcr/ytaa316. eCollection 2020 Oct.

Abstract

Background: Hypertrophic cardiomyopathy (HCM) is a genetically determined myocardial disease that constitutes the main cause of sudden cardiac death (SCD) in young athletes. Apical HCM (ApHCM) represents a complex subset of patients, whose risk of SCD seems not negligible. Most applied scores likely underestimate the risk of heart events in this subset of patients.

Case summary: We report the case of a 55-year-old man who was admitted in the emergency department after an episode of aborted sudden death due to ventricular fibrillation. The electrocardiogram made at admission was noted for atrial fibrillation and a new-onset left bundle branch block. Emergency coronary angiography was normal. The electrocardiogram was repeated and showed symmetrical and profound inversion of T waves in the lateral leads. Transthoracic echocardiogram and cardiac magnetic resonance revealed left ventricular apical hypertrophy suggestive of apical variant of HCM. A cardiac defibrillator was implanted for secondary prevention of SCD. After 6 months of follow-up no further rhythmic events were noted.

Discussion: Although low, the risk of SCD of ApHCM patients is not negligible. This case illustrates the need for searching of new predictors of rhythmic risk in patients with ApHCM.

Keywords: Apical hypertrophic cardiomyopathy; Case report; Hypertrophic cardiomyopathy; Implanted cardiac defibrillator; Secondary prevention; Sudden cardiac death.

Publication types

  • Case Reports